20 likes | 36 Views
The International Diabetic Federation, in its 10th edition 2021, gave quite a shocking revelation that approximately 537 million adults aged 20-79 years are living with diabetes. And about 1 in 2 (240 million) adults living undiagnosed diabetes. Among the available diagnostic methods hospitals and patients use is to prick their fingers and test in portable POCT/labs devices.<br><br>For the complete in-depth article on u2018Non-Invasive Glucose Monitoringu2019, please visit @ https://www.iebrain.com/non-invasive-glucose-monitoring/
E N D
Revolutionizing Diabetes Care: Non-Invasive GlucoseMonitoringTechnology TheInternationalDiabeticFederation,inits10thedition2021,gavequiteashockingrevelation that approximately 537 million adults aged 20-79 years are living with diabetes. And about 1 in2(240million)adultslivingundiagnoseddiabetes.Amongtheavailablediagnosticmethods hospitals and patients use is to prick their fingers and test in portable POCT/labs devices. The discomfort associated with the gradual punching has paved the way for many non-invasive measures for diagnosing diabetes. However, many questions remain to be answered about their accuracyandsensitivity. Movano has recently announced the completion of its pilot study developing smartwatch- based glucose monitoring wearables. Radio waves-based glucose monitoring is the principal technique behind this advancement. EVYA from the blue semi is a 9-sensor based healthcare gadget with 90 percent accuracy. The global Non-Invasive Glucose Meter market size is currently estimated to gain market growth in the forecast period of 2020 to 2025, pacing with a CAGR of 5.7% in this forecast period, i.e., 2020 to 2025. The market is expected to reach aboutUSD204.3 millionby2025,fromUSD163.4 millionin2019,clockingtoa25%increase. The non-invasive products usually fall into the wearable and non-wearable categories. The wearable is smartwatch-based sensors like Movano. The knowlabs Bio-RFID technology (Bio- RFID™)is the latestin the racefornon-invasive glucose wearables. An electromagnetic spectrum-based tech (spectroscopy-based) detects unique molecular signatures. The product is on the FDA list for approval and has recently received IRB Approval to initiate the Internal ClinicalTrials. Forthecompletein-deptharticleon‘Non-InvasiveGlucoseMonitoring’,pleasevisit@ https://www.iebrain.com/non-invasive-glucose-monitoring/ AboutIngeniouse-BrainSolutions: - Ingenious e-Brain Solutionsprovideshigh-quality, customized, and cost-effective Technology Intelligence,BusinessIntelligence, andIntellectualPropertyIntelligencesolutions toindustry leaders,andinnovativecompaniesacrosstheglobe.Innovation,knowledge,andtransparencyform thebasisofourcompany’smissionandvision.Alongwithcostbenefits,weprovidehighestquality results ensuring fool-proof confidentiality and security. We are an ISO certified company with offices inIndiaandUSA. Ingeniouse-BrainSolutionshasastrongteamof analysts,andsubjectmatterexpertswithdomain proficiency which is devoted to help clients grow. Our highly qualified professionals offer tailored, value-addedandcost-effectiveservicestoourclients.Webelieveinbuildinglongterm
relationshipswithourclientswhoincludenationalandinternationalcorporations,Fortune500 companies,world’sleadingresearchinstitutesanduniversitiesaswellasindependentinventors. GetinTouch:- IndiaOffice 207-208 Welldone TechPark,SohnaRoad Sector48,Gurugram,Haryana122018,India +911244294218 Email:- queries@iebrain.com